BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 15794852)

  • 21. Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenström's macroglobulinemia.
    Morice WG; Chen D; Kurtin PJ; Hanson CA; McPhail ED
    Mod Pathol; 2009 Jun; 22(6):807-16. PubMed ID: 19287458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is lymphoplasmacytic lymphoma/immunocytoma a distinct entity? A clinicopathologic study of 20 cases.
    Andriko JA; Swerdlow SH; Aguilera NI; Abbondanzo SL
    Am J Surg Pathol; 2001 Jun; 25(6):742-51. PubMed ID: 11395551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas.
    Gachard N; Parrens M; Soubeyran I; Petit B; Marfak A; Rizzo D; Devesa M; Delage-Corre M; Coste V; Laforêt MP; de Mascarel A; Merlio JP; Bouabdhalla K; Milpied N; Soubeyran P; Schmitt A; Bordessoule D; Cogné M; Feuillard J
    Leukemia; 2013 Jan; 27(1):183-9. PubMed ID: 22944768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
    Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
    N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia derives from an extensively hypermutated B cell that lacks ongoing somatic hypermutation.
    Walsh SH; Laurell A; Sundström G; Roos G; Sundström C; Rosenquist R
    Leuk Res; 2005 Jul; 29(7):729-34. PubMed ID: 15927667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia.
    Vitolo U; Ferreri AJ; Montoto S
    Crit Rev Oncol Hematol; 2008 Aug; 67(2):172-85. PubMed ID: 18499469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinicopathologic features of lymphoplasmacytic lymphoma].
    Liu EB; Zhang PH; Li ZQ; Sun Q; Yang QY; Fang LH; Sun FJ; Qiu LG
    Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):308-12. PubMed ID: 20654153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discriminating between Waldenström macroglobulinemia and marginal zone lymphoma using logistic LASSO regression.
    Amaador K; Vos JMI; Pals ST; Kraan W; Dobber JA; Minnema MC; Koene HR; de Bruin PC; Zwinderman AH; Kersten MJ
    Leuk Lymphoma; 2022 May; 63(5):1070-1079. PubMed ID: 34961399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myeloid nuclear differentiation antigen: an aid in differentiating lymphoplasmacytic lymphoma and splenic marginal zone lymphoma in bone marrow biopsies at presentation.
    Righi S; Novero D; Godio L; Bertuzzi C; Bacci F; Agostinelli C; Sagramoso C; Rossi M; Piccioli M; Gazzola A; Mannu C; Roncador G; Sabattini E
    Hum Pathol; 2022 Jun; 124():67-75. PubMed ID: 35339566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Identification of splenic marginal zone lymphoma from B lymphoproliferative disorders by flow cytometry].
    Hu Y; Chen Y; Wang LH; Chen X; Fang F; Liu SQ; Wu XQ; Zhu P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):349-56. PubMed ID: 24763004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Waldenström macroglobulinemia caused by extranodal marginal zone B-cell lymphoma: a report of six cases.
    Valdez R; Finn WG; Ross CW; Singleton TP; Tworek JA; Schnitzer B
    Am J Clin Pathol; 2001 Nov; 116(5):683-90. PubMed ID: 11710684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B-cell Non-Hodgkin Lymphomas with Plasmacytic Differentiation.
    Harmon CM; Smith LB
    Surg Pathol Clin; 2016 Mar; 9(1):11-28. PubMed ID: 26940265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Origin of Waldenstrom's macroglobulinaemia.
    García-Sanz R; Jiménez C; Puig N; Paiva B; Gutiérrez NC; Rodríguez-Otero P; Almeida J; San Miguel J; Orfão A; González M; Pérez-Andrés M
    Best Pract Res Clin Haematol; 2016 Jun; 29(2):136-147. PubMed ID: 27825459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features.
    Zukerberg LR; Medeiros LJ; Ferry JA; Harris NL
    Am J Clin Pathol; 1993 Oct; 100(4):373-85. PubMed ID: 8213632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinicopathologic features and differential diagnosis of splenic B-cell marginal zone lymphoma involving bone marrow].
    Sun Q; Zhang PH; Liu EB; Liu W; Li ZQ; Yang QY; Fang LH; Sun FJ; Chen HS; Qiu LG
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):234-8. PubMed ID: 23928529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinctive clinical and histological features of Waldenström's macroglobulinemia and splenic marginal zone lymphoma.
    Arcaini L; Varettoni M; Boveri E; Orlandi E; Rattotti S; Zibellini S; Merli M; Lucioni M; Rizzi S; Gotti M; Morello L; Pascutto C; Paulli M
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):103-5. PubMed ID: 21454204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defining Lymphoplasmacytic Lymphoma: Does MYD88L265P Define a Pathologically Distinct Entity Among Patients With an IgM Paraprotein and Bone Marrow-Based Low-Grade B-Cell Lymphomas With Plasmacytic Differentiation?
    Fang H; Kapoor P; Gonsalves WI; Frederick LA; Viswanatha D; Howard MT; He R; Morice WG; McPhail ED; Greipp PT; Ansell SM; Kyle RA; Gertz MA; Paludo J; Abeykoon J; King RL
    Am J Clin Pathol; 2018 Jul; 150(2):168-176. PubMed ID: 29868855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B-zone small lymphocytic lymphoma: a morphologic, immunophenotypic, and clinical study with comparison to "well-differentiated" lymphocytic disorders.
    Carbone A; Pinto A; Gloghini A; Volpe R; Zagonel V
    Hum Pathol; 1992 Apr; 23(4):438-48. PubMed ID: 1563746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphoplasmacytic lymphoma/immunocytoma: towards a disease-targeted treatment?
    Clavio M; Quintino S; Venturino C; Ballerini F; Varaldo R; Gatto S; Galbusera V; Garrone A; Grasso R; Canepa L; Miglino M; Pierri I; Gobbi M
    J Exp Clin Cancer Res; 2001 Sep; 20(3):351-8. PubMed ID: 11718214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological correlates of IgM paraproteinemias.
    Owen RG; Parapia LA; Higginson J; Misbah SA; Child JA; Morgan GJ; Jack AS
    Clin Lymphoma; 2000 Jun; 1(1):39-43; discussion 44-5. PubMed ID: 11707811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.